BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 34360768)

  • 41. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.
    Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
    Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
    Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR
    Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.
    Wang DP; Kang K; Lin Q; Hai J
    Clin Transl Sci; 2020 Jan; 13(1):179-188. PubMed ID: 31550075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer.
    Zhou ZQ; Pang S; Yu XC; Xue Q; Jiang HY; Liang XJ; Liu L
    Curr Med Sci; 2018 Oct; 38(5):798-808. PubMed ID: 30341514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinoma.
    Yang Y; Xu H; Zhou L; Deng T; Ning T; Liu R; Zhang L; Wang X; Ge S; Li H; Ba Y
    Clin Chim Acta; 2018 Apr; 479():160-165. PubMed ID: 29325800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.
    Itami Y; Miyake M; Tatsumi Y; Gotoh D; Hori S; Morizawa Y; Iida K; Ohnishi K; Nakai Y; Inoue T; Anai S; Tanaka N; Shimada K; Hirao S; Fujimoto K
    Int J Clin Oncol; 2019 May; 24(5):533-545. PubMed ID: 30604161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.
    Zhang L; Su Y; Chen Z; Wei Z; Han W; Xu A
    Medicine (Baltimore); 2017 Jul; 96(30):e7647. PubMed ID: 28746229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
    You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
    Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.
    Cantiello F; Russo GI; Vartolomei MD; Farhan ARA; Terracciano D; Musi G; Lucarelli G; Di Stasi SM; Hurle R; Serretta V; Busetto GM; Scafuro C; Perdonà S; Borghesi M; Schiavina R; Cioffi A; De Berardinis E; Almeida GL; Bove P; Lima E; Ucciero G; Matei DV; Crisan N; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Mirone V; Shariat SF; Ferro M
    Eur Urol Oncol; 2018 Oct; 1(5):403-410. PubMed ID: 31158079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
    Yang J; Xu H; Guo X; Zhang J; Ye X; Yang Y; Ma X
    Sci Rep; 2018 Feb; 8(1):3044. PubMed ID: 29445100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
    Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
    Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.
    Nakagawa K; Sho M; Akahori T; Nagai M; Nakamura K; Takagi T; Tanaka T; Nishiofuku H; Ohbayashi C; Kichikawa K; Ikeda N
    Pancreatology; 2019 Jul; 19(5):722-728. PubMed ID: 31153778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
    Matsuda A; Yamada T; Matsumoto S; Sakurazawa N; Kawano Y; Shinozuka E; Sekiguchi K; Suzuki H; Yoshida H
    Anticancer Res; 2019 Aug; 39(8):4343-4350. PubMed ID: 31366528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.
    Miyake M; Morizawa Y; Hori S; Marugami N; Iida K; Ohnishi K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
    Oncology; 2017; 93(4):259-269. PubMed ID: 28647740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.